Connect

Funding supports development of ATC-001, a Z-pod®-based anandamide formulation for local delivery to cutaneous lupus lesions

New hire brings experience in business development, program management and entrepreneurship to lead board, sponsor and partner relationships at the 40-year-old nonprofit.

New hire brings seven years of hands-on marketing and campaign experience to support Connect's events, storytelling and brand presence across San Diego's innovation community.

Two-year NHLBI CATALYZE award supports clinical validation of the AmyFold Assay, a blood-based test designed to detect transthyretin amyloidosis before irreversible cardiac damage.

The new site brings every episode of The Connect Current podcast into one home, updating automatically with each release and spotlighting the founders and investors building San Diego's future.

Founders, venture firms and ecosystem organizations can leverage Connect's 40 years of credibility, expertise and regional reach to share important news.

New office strengthens Connect's presence across San Diego's innovation corridors and expands access for founders, partners and community members.

Funding will support development of HepTol™, a liver-targeted mRNA-LNP platform designed to prevent disease progression in T1D patients

Annual event brings together research institutions, founders, investors and ecosystem leaders

Vayim, a San Diego medical technology company and Connect Springboard company, will use the investment to advance its minimally invasive technology for chronic rhinosinusitis (CRS).